Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert A Taylor

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Trials (London, England)|July 2, 2019
Design and analysis of a clinical trial using previous trials as historical controlDavid Alan Schoenfeld, Dianne M Finkelstein, Eric Macklin, et al.
Annals of Clinical and Translational Neurology|November 16, 2016
Predicting disease progression in amyotrophic lateral sclerosisAlbert A Taylor, Christina Fournier, Meraida Polak, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 21, 2017
Longitudinal modeling to predict vital capacity in amyotrophic lateral sclerosisSamad Jahandideh, Albert A Taylor, Danielle Beaulieu, et al.
Annals of Clinical and Translational Neurology|April 25, 2018
Improved stratification of ALS clinical trials using predicted survivalJames D Berry, Albert A Taylor, Danielle Beaulieu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 12, 2021
Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis toolBenjamin Rix Brooks, Erik P Pioro, Danielle Beaulieu, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 24, 2015
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Neta Zach, David L Ennist, Albert A Taylor, et al.
Annals of Clinical and Translational Neurology|December 20, 2018
Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosisKatharine Nicholson, James Chan, Eric A Macklin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Trials (London, England)|July 2, 2019
Design and analysis of a clinical trial using previous trials as historical controlDavid Alan Schoenfeld, Dianne M Finkelstein, Eric Macklin, et al.
Annals of Clinical and Translational Neurology|November 16, 2016
Predicting disease progression in amyotrophic lateral sclerosisAlbert A Taylor, Christina Fournier, Meraida Polak, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 21, 2017
Longitudinal modeling to predict vital capacity in amyotrophic lateral sclerosisSamad Jahandideh, Albert A Taylor, Danielle Beaulieu, et al.
Annals of Clinical and Translational Neurology|April 25, 2018
Improved stratification of ALS clinical trials using predicted survivalJames D Berry, Albert A Taylor, Danielle Beaulieu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 12, 2021
Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis toolBenjamin Rix Brooks, Erik P Pioro, Danielle Beaulieu, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 24, 2015
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Neta Zach, David L Ennist, Albert A Taylor, et al.
Annals of Clinical and Translational Neurology|December 20, 2018
Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosisKatharine Nicholson, James Chan, Eric A Macklin, et al.
Pageof 1